Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (<scp>CRSwNP</scp>): A multicentric observational Phase IV real‐life study (<scp>DUPIREAL</scp>)

De Corso, Eugenio; Pasquini, Ernesto; Trimarchi, Matteo; La Mantia, Ignazio; Pagella, Fabio; Ottaviano, Giancarlo; Garzaro, Massimiliano; Pipolo, Carlotta; Torretta, Sara; Seccia, Veronica; Cantone, Elena; Ciofalo, Andrea; Lucidi, Daniela; Luca Fadda, Gian; Clara Pafundi, Pia; Settimi, Stefano; Montuori, Claudio; Anastasi, Francesca; Pagliuca, Giulio; Ghidini, Angelo; Cavaliere, Carlo; Maffei, Marianna; Bussu, Francesco; Gallo, Stefania; Rikki Mauritz Canevari, Frank; Paludetti, Gaetano; Galli, Jacopo; Italian Study Group, Dupireal

doi:10.1111/all.15772

Public

Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (<scp>CRSwNP</scp>): A multicentric observational Phase IV real‐life study (<scp>DUPIREAL</scp>)

Shared by NobleBlocks on May 26, 2023 • 12:00 AM UTC

Authors:

Eugenio De Corso

Ernesto Pasquini

Matteo Trimarchi

Abstract

Abstract Background Chronic rhinosinusitis with nasal polyps (CRSwNP) is associated with significant morbidity and reduced health‐related quality of life. Findings from clinical trials have demonstrated the effectiveness of dupilumab in CRSwNP, although real‐world evidence is still limited. Methods ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!